Solute carrier family 2, facilitated glucose transporter member 6 is a protein that in humans is encoded by the SLC2A6 gene .[5] [6]
Function [ ]
Hexose transport into mammalian cells is catalyzed by a family of membrane proteins, including SLC2A6, that contain 12 transmembrane domains and a number of critical conserved residues.[supplied by OMIM][6]
See also [ ]
References [ ]
^ a b c ENSG00000281165 GRCh38: Ensembl release 89: ENSG00000160326, ENSG00000281165 - Ensembl , May 2017
^ a b c GRCm38: Ensembl release 89: ENSMUSG00000036067 - Ensembl , May 2017
^ "Human PubMed Reference:" . National Center for Biotechnology Information, U.S. National Library of Medicine .
^ "Mouse PubMed Reference:" . National Center for Biotechnology Information, U.S. National Library of Medicine .
^ Doege H, Bocianski A, Joost HG, Schürmann A (September 2000). "Activity and genomic organization of human glucose transporter 9 (GLUT9), a novel member of the family of sugar-transport facilitators predominantly expressed in brain and leucocytes" . The Biochemical Journal . 350 Pt 3 (Pt 3): 771–6. doi :10.1042/0264-6021:3500771 . PMC 1221309 . PMID 10970791 .
^ a b "Entrez Gene: SLC2A6 solute carrier family 2 (facilitated glucose transporter), member 6" .
Further reading [ ]
Maruyama K, Sugano S (January 1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene . 138 (1–2): 171–4. doi :10.1016/0378-1119(94)90802-8 . PMID 8125298 .
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (October 1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene . 200 (1–2): 149–56. doi :10.1016/S0378-1119(97)00411-3 . PMID 9373149 .
Richardson S, Neama G, Phillips T, Bell S, Carter SD, Moley KH, Moley JF, Vannucci SJ, Mobasheri A (February 2003). "Molecular characterization and partial cDNA cloning of facilitative glucose transporters expressed in human articular chondrocytes; stimulation of 2-deoxyglucose uptake by IGF-I and elevated MMP-2 secretion by glucose deprivation" . Osteoarthritis and Cartilage . 11 (2): 92–101. doi :10.1053/joca.2002.0858 . PMID 12554125 .
Otsuki T, Ota T, Nishikawa T, Hayashi K, Suzuki Y, Yamamoto J, Wakamatsu A, Kimura K, Sakamoto K, Hatano N, Kawai Y, Ishii S, Saito K, Kojima S, Sugiyama T, Ono T, Okano K, Yoshikawa Y, Aotsuka S, Sasaki N, Hattori A, Okumura K, Nagai K, Sugano S, Isogai T (2007). "Signal sequence and keyword trap in silico for selection of full-length human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA libraries" . DNA Research . 12 (2): 117–26. doi :10.1093/dnares/12.2.117 . PMID 16303743 .
This article incorporates text from the United States National Library of Medicine , which is in the public domain .
By group
SLC1–10
(1):
high affinity glutamate and neutral amino-acid transporter
(2): (3): (4): (5): (6): (7): (8): (9): (10):
SLC10A1
SLC10A2
SLC10A3
SLC10A7
10A1
10A2
10A3
10A7
SLC11–20
(11): (12): (13): (14): (15): (16): (17): (18): (19): (20):
SLC21–30
(21):
Organic anion-transporting polypeptide
SLCO1A2
SLCO1B1
SLCO1B3
SLCO1C1
(22):
organic cation/anion/zwitterion transporter
(23): (24): (25): (26): (27): (28): (29): (30):
zinc efflux
SLC30A1
SLC30A3
SLC30A4
SLC30A7
SLC30A8
SLC31–40
(31): (32): (33): (34): (35): (36): (37): (38): (39):
metal ion transporter
SLC39A1
SLC39A2
SLC39A3
SLC39A4
SLC39A6
SLC39A7
SLC39A8
SLC39A9
SLC39A10
SLC39A12
(40):
SLC41–48
(41): (42): (43): (44): (45): (46): (47): (48):
SLCO1–4
O1A2
O1B1
O1B3
O2B1
O431
O4A1
see also solute carrier disorders